Insoluble TATA-binding protein accumulation in Huntington's disease cortex

Molecular Brain Research

Volumn 109, Issue 1-2, 2002, Pages 1-10

  Van Roon Mom, Willeke M C ^a   Reid, Suzanne J ^a   Jones, A Lesley ^b   MacDonald, Marcy E ^c   Faull, Richard L M ^a   Snell, Russell G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Human brain; Huntingtin; Huntington's disease; Middle frontal gyrus; Polyglutamine; TATA binding protein

Indexed keywords

AMINO ACID; GLUTAMINE; HUNTINGTIN; POLYGLUTAMINE; TATA BINDING PROTEIN;

ADULT; AGED; ALLELE; AMINO ACID COMPOSITION; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SOLUBILITY;

ADULT; AGED; AGED, 80 AND OVER; CELL SIZE; CEREBRAL CORTEX; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN ISOFORMS; TATA-BOX BINDING PROTEIN;

EID: 12244300919     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00450-3     Document Type: Article

References (48)

1. Aronin N., Chase K., Young C., Sapp E., Schwarz C., Matta N., Kornreich R., Landwehrmeyer B., Bird E., Flint Beal M., Vonsattel J.-P., Smith T., Carraway R., Boyce F.M., Young A.B., Penney J.B., DiFiglia M. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron. 15:1995;1193-1201.
2. Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S., Jones A.L. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet. 8:1999;1647-1655.
3. Cha J.-H.J. Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23:2000;387-392.
4. Cummings C.J., Zoghbi H.Y. Fourteen and counting: unraveling trinucleotide repeat diseases. Hum. Mol. Genet. 9:2000;909-916.
5. Davies S.W., Turmaine M., Cozens B.A., Difiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the hd mutation. Cell. 90:1997;537-548.
6. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.-P., Carraway R., Reeves S.A., Boyce F.M., Aronin N. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14:1995;1075-1081.
7. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
8. Gerber H.P., Seipel K., Georgiev O., Höfferer M., Hug M., Rusconi S., Schaffner W. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 263:1994;808-811.
9. Gostout B., Liu Q., Sommer S.S. 'Cryptic' repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am. J. Hum. Genet. 52:1993;1182-1190.
10. Gourfinkel-An I., Cancel G., Duyckaerts C., Faucheux B., Hauw J.-J., Trottier Y., Brice A., Agid Y., Hirsch E.C. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset. Neuroreport. 9:1998;1823-1826.
11. Gutekunst C.-A., Li S.-H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., Li X.-J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19:1999;2522-2534.
12. Hoffman A., Sinn E., Yamamoto T., Wang J., Roy A., Horikoshi M., Roeder R.G. Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature. 346:1990;387-390.
13. Hoogeveen A.T., Willemsen R., Meyer N., de Rooij K.E., Roos R.A.C., van Ommen G.-J.B., Galjaard H. Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2:1993;2069-2073.
14. Huang C.C., Faber P.W., Persichetti F., Mittal V., Vonsattel J.-P., MacDonald M.E., Gusella J.F. Amyloid formation by mutant huntingtin: Threshold progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24:1998;217-233.
15. Kaytor M.D., Warren S.T. Aberrant protein deposition and neurological disease. J. Biol. Chem. 274:1999;37507-37510.
16. Koide R., Kobayashi S., Shimohata T., Ikeuchi T., Maruyama M., Saito M., Yamada M., Takahashi H., Tsuji S. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease. Hum. Mol. Genet. 18:1999;2047-2053.
17. Kuemmerle S., Gutekunst C.-A., Klein A.M., Li X.-J., Li S.-H., Flint Beal M., Hersch S.M., Ferrante R.J. Huntingtin aggregates may not predict neuroneal death in Huntington's disease. Ann. Neurol. 46:1999;842-849.
18. Li S.H., Li X.J. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7:1998;777-782.
19. Lin X., Antalffy B., Kang D., Orr H.T., Zoghbi H.Y. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 3:2000;157-163.
20. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.H., Olson J.M. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9:2000;1259-1271.
21. Martinez E., Zhou Q.A., Letoile N.D., Oelgeschlager T., Berk A.J., Roeder R.G. Core promoter-specific function of a mutant transcription factor TFIID defective in Tata-box binding. Proc. Natl. Acad. Sci. USA. 92:1995;11864-11868.
22. McGowan D.P., van Roon-Mom W., Holloway H., Bates G.P., Mangiarini L., Cooper G.J.S., Faull R.L.M., Snell R.G. Amyloid-like inclusions in Huntington's disease. Neuroscience. 100:2000;677-680.
23. Mhatre A.N., Trifiro M.A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 5:1993;184-188.
24. Nakamura K., Jeong S.-Y., Iuchihara T., Anno M., Nagashima K., Nagashima T., Ikeda S.-i., Tsuji S., Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10:2001;1441-1448.
25. Nucifora F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., Ross C.A. Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science. 291:2001;2423-2428.
26. Ordway J.M., Tallaksen-Greene S., Gutekunst C.-A., Bernstein E.M., Cearley J.A., Wiener H.W., Dure L.S., Lindsey R., Hersch S.M., Jope R.S., Albin R.L., Detloff P.J. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91:1997;753-763.
27. Paulson H.L., Perez M.K., Trottier Y., Trojanowski J.Q., Subramony S.H., Das S.S., Vig P., Mandel J.L., Fischbeck K.H., Pittman R.N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia Type 3. Neuron. 19:1997;333-344.
28. Perez M.K., Paulson H.L., Pendse S.J., Saionz S.J., Bonini N.M., Pittman R.N. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143:1998;1457-1470.
29. Perutz M.F., Johnson T., Suzuci M., Finch J.T. Glutamine repeats as polar zipper: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 91:1994;5355-5358.
30. Perutz M.F., Windle A.H. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature. 412:2001;143-144.
31. Peters M.F., Nucifora F.C., Kushi J., Seaman H.C., Cooper J.K., Herring W.J., Dawson V.L., Dawson T.M., Ross C.A. Nuclear targeting of mutant huntingtin increases toxicity. Mol. Cell. Neurosci. 14:1999;121-128.
32. Rich T., Assier E., Skepper J., Segard H.B., Allen R.L., Charron D., Trowsdale J. Disassembly of nuclear inclusions in the dividing cell - a novel insight into neurodegeneration. Hum. Mol. Genet. 8:1999;2451-2459.
33. Ross C.A. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 19:1997;1147-1150.
34. Rubinsztein D.C., Leggo J., Crow T.J., DeLisi L.E., Walsh C., Jain S., Paykel E. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder. Am. J. Med. Genet. 67:1996;495-498.
35. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
36. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bated G.P., Davies S.W., Lehrach H., Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregated in vitro and in vivo. Cell. 90:1997;549-558.
37. Schilling G., Becher M.W., Sharp A.H., Jinnah H.A., Duan K., Kotzuk J.A., Slunt H.H., Ratovitski T., Cooper J.K., Jenkins N.A., Copeland N.G., Price D.L., Ross C.A., Borchelt D.R. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8:1999;397-407.
38. Sharp P.A. TATA-binding protein is a classless factor. Cell. 68:1992;819-821.
39. Sieradzan K.A., Mechan A.O., Jones L., Wanker E.E., Nukina N., Mann D.M.A. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp. Neurol. 156:1999;92-99.
40. Skinner P.J., Koshy B.T., Cummings C.J., Klement I.A., Helin K., Servadio A., Zoghbi H.Y., Orr H.T. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 389:1997;971-974.
41. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA. 97:2000;6763-6768.
42. Stott K., Blackburn J.M., Butler P.J.G., Perutz M. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 92:1995;6509-6513.
43. Vonsattel J.-P.G., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384.
44. Vonsattel J.-P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
45. Whitefield J.E., Williams L., Dixon J., Winship I., Stapleton P.M., Faull R.L.M., Love D.R. Molecular analysis of the Huntington's disease gene in New Zealand. New Zealand Med. J. 9:1996;27-30.
46. Wilkinson F.L., Man N.T., Manilal S.B., Thomas P., Neal J.W., Harper P.S., Jones A.L., Morris G.E. Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Mol. Brain Res. 69:1999;10-20.
47. Yanagisawa H., Bundo M., Miyashita T., Okamura-Oho Y., Tadokoro K., Tokunaga K., Yamada M. Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine. Hum. Mol. Genet. 8:2000;1433-1442.
48. Zuhlke C., Hellenbroich Y., Dalski A., Kononowa N., Hagenah J., Vieregge P., Riess O., Klein C., Schwinger E. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur. J. Hum. Genet. 9:2001;160-164.